Navigation Links
Monitor for sunburn risk goes on sale
Date:5/8/2014

A monitor developed at the University of Strathclyde in Glasgow for preventing the risk of over exposure to the sun is now available for sale online.

The Smartsun device, worn as a waterproof wristband, changes colour according to the amount of exposure the wearer has to UV (ultra-violet) radiation. It starts off yellow but turns pink as exposure increases, warning users to get out of the sun.

The monitor's sensitivity to ultraviolet light means it can alert the wearer to the danger before it is visible on the skin.

The monitor is now available in the UK through eChemist, and PharmacyKwik, at 6.99 for a pack of seven bands.

Prolonged exposure to the sun can increase the risk of skin cancer. The rates of the most virulent form of this cancer, malignant melanoma, are now five times higher than 40 years ago, with diagnoses in 17 people per 100,000 each year, compared with three per 100,000 in the 1970s, according to Cancer Research UK statistics. Malignant melanoma caused 2,209 deaths in the UK in 2011.

Smartsun is being marketed by Swedish-based company Intellego Technologies, established by entrepreneur Claes Lindahl. Professor Andrew Mills and Dr Michael McFarlane, who developed the original invention while they were previously with Strathclyde's Department of Pure and Applied Chemistry, are engaged as consultants to Intellego.

Mr Lindahl said: "During the last two years the Smartsun wristband has gone through extensive testing and customer feedback in order to create a product with high functionality and ease of use. We are very happy with the customer feedback , and hopefully we can help to make the summer more enjoyable for the UK users of our wristbands."

Stuart Mackenzie, Commercialisation Infrastructure Manager with the University of Strathclyde's Research & Knowledge Exchange Services, said: "Strathclyde is a leading international technological university where impact and innovation are at the heart of our research activity.

"Smartsun will continue this tradition as a protective and preventative device benefiting public health. We have high hopes for Intellego's future as it brings this technology to the UK and international market."

The Smartsun monitor works through a significant colour change, created by an acid-release agent which detects ultraviolet light and a dye responding to pH levels in the indicator. The agent is decomposed by sunlight, leading to the rapid colour change.

The development of the device received initial funding and support from Scottish Enterprise's Proof of Concept Programme, which is partly funded by the European Union.

Smartsun has been approved by Skcin, the Karen Clifford Skin Cancer Charity and a donation will be made to the charity from each sale.

Smartsun is being distributed in the UK by Smartsun UK Distributors Ltd. More information can be seen at http://www.smartsunband.com or by contacting info@smartsun.se


'/>"/>

Contact: Press Office
corporatecomms@strath.ac.uk
44-014-154-82370
University of Strathclyde
Source:Eurekalert  

Related medicine news :

1. Drug monitoring information improves regimen adherence, Carnegie Mellon researchers say
2. Following a proteins travel inside cells is key to improving patient monitoring, drug development
3. Alzheimers prevention trial to monitor reactions to higher disease risk status
4. New research to revolutionize healthcare through remote monitoring of patients
5. Fleet Management Market (Analytics, Vehicle Tracking, Monitoring) Worth $30.45 Billion By 2018 - New Report by MarketsandMarkets
6. Patient Monitoring Systems Market (Equipments & Systems) Worth $18.9 Billion by 2016 - New Report by MarketsandMarkets
7. Narconon Arrowhead Oklahoma Featured In Scientific Journal for Outcome Monitoring Procedure
8. China Medical Monitor Industry 2013 Analysis & 2015 Forecasts in New Research Report at ChinaMarketResearchReports.com
9. PM2.5 Monitor Industry in Global and China Regions 2013 Analysis in a New Study at DeepResearchReports.com
10. Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring
11. Clinical waste may prove valuable for monitoring treatment response in ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Monitor for sunburn risk goes on sale
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and ... This is in conjunction with this morning,s announcement of ... Thrombosis and Nutritional Insufficiency businesses. Cardinal Health ... operations will be at the bottom of its previous ...
Breaking Medicine Technology: